These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9685513)

  • 1. Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus.
    Rosato MT; Schneider SH; Shapses SA
    Calcif Tissue Int; 1998 Aug; 63(2):107-11. PubMed ID: 9685513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vitamin D-fortified low fat yogurt on glycemic status, anthropometric indexes, inflammation, and bone turnover in diabetic postmenopausal women: A randomised controlled clinical trial.
    Jafari T; Faghihimani E; Feizi A; Iraj B; Javanmard SH; Esmaillzadeh A; Fallah AA; Askari G
    Clin Nutr; 2016 Feb; 35(1):67-76. PubMed ID: 25794439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intensive glycemic control on serum levels of insulin-like growth factor-I and dehydroepiandrosterone sulfate in Type 2 diabetes mellitus.
    Kanazawa I; Yamaguchi T; Sugimoto T
    J Endocrinol Invest; 2012 May; 35(5):469-72. PubMed ID: 21997284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between glycosylated hemoglobin A1c and bone biochemical markers in type 2 diabetic postmenopausal women: a cross-sectional study.
    Wang L; Li T; Liu J; Wu X; Wang H; Li X; Xu E; Chen Q; Yan C; Li H; Xu Y; Wei W
    BMC Endocr Disord; 2019 Mar; 19(1):31. PubMed ID: 30866902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover.
    Okazaki R; Totsuka Y; Hamano K; Ajima M; Miura M; Hirota Y; Hata K; Fukumoto S; Matsumoto T
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2915-20. PubMed ID: 9284719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment with troglitazone decreases bone turnover in patients with type 2 diabetes mellitus.
    Okazaki R; Miura M; Toriumi M; Taguchi M; Hirota Y; Fukumoto S; Fujita T; Tanaka K; Takeuchi A
    Endocr J; 1999 Dec; 46(6):795-801. PubMed ID: 10724355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing serum osteocalcin after glycemic control in diabetic men.
    Sayinalp S; Gedik O; Koray Z
    Calcif Tissue Int; 1995 Dec; 57(6):422-5. PubMed ID: 8581873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
    Hotta M; Fukuda I; Sato K; Hizuka N; Shibasaki T; Takano K
    J Clin Endocrinol Metab; 2000 Jan; 85(1):200-6. PubMed ID: 10634387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.
    Ghiron LJ; Thompson JL; Holloway L; Hintz RL; Butterfield GE; Hoffman AR; Marcus R
    J Bone Miner Res; 1995 Dec; 10(12):1844-52. PubMed ID: 8619364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age.
    Lieuw-A-Fa M; Sierra RI; Specker BL
    J Bone Miner Res; 1995 Jun; 10(6):849-53. PubMed ID: 7572307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients.
    El-Mesallamy HO; Hamdy NM; Sallam AA
    Acta Diabetol; 2013 Oct; 50(5):679-85. PubMed ID: 22307870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes.
    Inaba M; Nishizawa Y; Mita K; Kumeda Y; Emoto M; Kawagishi T; Ishimura E; Nakatsuka K; Shioi A; Morii H
    Osteoporos Int; 1999; 9(6):525-31. PubMed ID: 10624460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity.
    Arnetz L; Hage C; Ekberg NR; Alvarsson M; Brismar K; Norhammar A; Mellbin L
    Growth Horm IGF Res; 2015 Dec; 25(6):298-303. PubMed ID: 26283275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.